ArticleAmerican journal of translational research2023
Outcome effects of enalapril with or without bisoprolol in patients with acute myocardial infarction.
Article in American journal of translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study was designed to determine the effects of enalapril combined with bisoprolol on patients with acute myocardial infarction (AMI) and their prognosis.
methodsThis study retrospectively analyzed data of 104 patients receiving AMI treatment in the First People's Hospital of Shanghai from May 2019 to October 2021, including 48 patients treated with enalapril alone (control group) and 56 patients treated with enalapril combined with bisoprolol (observation group). The efficacy, adverse reactions, cardiac function [left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVED), left ventricular end-systolic diameter (LVES) and left ventricular mass (LVM)] of the two groups were measured and analyzed. The patients were followed up for one year to compare their prognosis.
resultsThe observation group showed a significantly higher total response rate than the control group (P < 0.05), but the incidence of adverse reactions was not different significantly between the two groups (P > 0.05). After treatment, LVES, LVED and LVEF increased significantly in both groups (P < 0.05), and the observation group showed significantly lower LVES and LVM levels and had a higher LVEF level than the control group (P < 0.05). The follow-up results revealed no significant difference in prognosis and survival between the two groups (P > 0.05).
conclusionEnalapril combined with bisoprolol is effective and safe in the treatment of AMI, because this regimen can effectively improve patients' cardiac function.
Indexed as
Identifiers
37056813PMC10086879W4365479644What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.